In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alligator Bioscience AB

http://www.alligatorbioscience.se//en/

Latest From Alligator Bioscience AB

Idogen Running Out Of Survival Options

With very little cash left in the bank, Idogen is weighing up its options including a reverse merger or liquidation.

Financing Business Strategies

Horizon Scores In Second Round Of Sjögren’s Trial A Month After Amgen Buyout

The company announced positive results in the second population of its Phase II study of dazodalibep in patients with Sj

Clinical Trials Inflammation

Alligator Makes Advances In Pancreatic Cancer

The Swedish biotech is expecting intense discussions with prospective partners for mitazalimab, a couple of years after Janssen returned the rights to the CD40 agonist.

Cancer Clinical Trials

Orion Exits Neuro To Concentrate On Cancer And Pain

Rather than making smaller investments in a larger number of areas, Orion is putting its research euros into oncology and pain management and pulling its Parkinson’s and Alzheimer’s projects, as well as its rare disease programs.

Research & Development Cancer
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
UsernamePublicRestriction

Register